Advertisement

Personalized Medicine in ADHD and Depression: Use of Pharmaco-EEG

  • Martijn ArnsEmail author
  • Sebastian Olbrich
Part of the Current Topics in Behavioral Neurosciences book series (CTBN, volume 21)

Abstract

This chapter summarises recent developments on personalised medicine in psychiatry with a focus on ADHD and depression and their associated biomarkers and phenotypes. Several neurophysiological subtypes in ADHD and depression and their relation to treatment outcome are reviewed. The first important subgroup consists of the ‘impaired vigilance’ subgroup with often-reported excess frontal theta or alpha activity. This EEG subtype explains ADHD symptoms well based on the EEG Vigilance model, and these ADHD patients responds well to stimulant medication. In depression this subtype might be unresponsive to antidepressant treatments, and some studies suggest these depressive patients might respond better to stimulant medication. Further research should investigate whether sleep problems underlie this impaired vigilance subgroup, thereby perhaps providing a route to more specific treatments for this subgroup. Finally, a slow individual alpha peak frequency is an endophenotype associated with treatment resistance in ADHD and depression. Future studies should incorporate this endophenotype in clinical trials to investigate further the efficacy of new treatments in this substantial subgroup of patients.

Keywords

ADHD Depression QEEG Personalised medicine Phenotype Biomarker 

Notes

Acknowledgment

This work has been adapted and updated from the PhD thesis: ‘Personalized medicine in ADHD and Depression: A quest for EEG treatment predictors’ by Martijn Arns.

References

  1. Adamaszek M, Olbrich S, Gallinat J (2011) The diagnostic value of clinical EEG in detecting abnormal synchronicity in panic disorder. Clin EEG Neurosci 42(3):166–174PubMedGoogle Scholar
  2. Adrian ED, Matthews BHC (1934) The Berger rhythm: potential changes from the occipital lobes in man. Brain: J Neurol 57(4):355Google Scholar
  3. Anokhin A, Steinlein O, Fischer C, Mao Y, Vogt P, Schalt E, Vogel F (1992) A genetic study of the human low-voltage electroencephalogram. Hum Genet 90(1–2):99–112PubMedGoogle Scholar
  4. Arns M (2012) EEG-based personalized medicine in ADHD: Individual alpha peak frequency as an endophenotype associated with nonresponse. J Neurotherapy 16(2):123–141Google Scholar
  5. Arns M, Kenemans JL (2012) Neurofeedback in ADHD and insomnia: vigilance stabilization through sleep spindles and circadian networks. Neurosci Biobehav Rev. doi: 10.1016/j.neubiorev.2012.10.006
  6. Arns M, Conners CK, Kraemer HC (2013a) A decade of EEG theta/beta ratio research in ADHD: a meta-analysis. J Attention Disord 17(5):374–383Google Scholar
  7. Arns M, Drinkenburg WHIM, Kenemans JL (2012a) The effects of QEEG-informed neurofeedback in ADHD: an open-label pilot study. Appl Psychophysiol Biofeedback 37(3):171–180PubMedCentralPubMedGoogle Scholar
  8. Arns M, Drinkenburg WHIM, Fitzgerald PB, Kenemans JL (2012b) Neurophysiological predictors of non-response to rTMS in depression. Brain Stimulation 5:569–576PubMedGoogle Scholar
  9. Arns M, Gunkelman J, Breteler M, Spronk D (2008) EEG phenotypes predict treatment outcome to stimulants in children with ADHD. J Integr Neurosci 7(3):421–438PubMedGoogle Scholar
  10. Arns M, Spronk D, Fitzgerald PB (2010) Potential differential effects of 9 and 10 Hz rTMS in the treatment of depression. Brain Stimulation 3(2):124–126PubMedGoogle Scholar
  11. Arns M, van der Heijden KB, Arnold LE, Kenemans JL (2013b) Geographic variation in the prevalence of attention-deficit/hyperactivity disorder: the sunny perspective. Biol Psychiatry. doi: 10.1016/j.biopsych.2013.02.010 Google Scholar
  12. Asada H, Fukuda Y, Tsunoda S, Yamaguchi M, Tonoike M (1999) Frontal midline theta rhythms reflect alternative activation of prefrontal cortex and anterior cingulate cortex in humans. Neurosci Lett 274(1):29–32PubMedGoogle Scholar
  13. Astill RG, Van der Heijden KB, Van Ijzendoorn MH, Van Someren EJ (2012) Sleep, cognition, and behavioral problems in school-age children: a century of research meta-analyzed. Psychol Bull 138:155–159Google Scholar
  14. Axelsson J, Kecklund G, Åkerstedt T, Donofrio P, Lekander M, Ingre M (2008) Sleepiness and performance in response to repeated sleep restriction and subsequent recovery during semi-laboratory conditions. Chronobiol Int 25(2–3):297–308PubMedGoogle Scholar
  15. Bagby RM, Ryder AG, Cristi C (2002) Psychosocial and clinical predictors of response to pharmacotherapy for depression. J Psychiatry Neurosci: JPN 27(4):250–257PubMedCentralPubMedGoogle Scholar
  16. Bares M, Brunovsky M, Kopecek M, Novak T, Stopkova P, Kozeny J, Sos P, Krajca V, Höschl C (2008) Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder. European Psychiatry: J Assoc Eur Psychiatrists 23(5):350–355Google Scholar
  17. Bares M, Brunovsky M, Kopecek M, Stopkova P, Novak T, Kozeny J, Höschl C (2007) Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study. J Psychiatr Res 41(3–4):319–325PubMedGoogle Scholar
  18. Bares M, Brunovsky M, Novak T, Kopecek M, Stopkova P, Sos P, Krajca V, Höschl C (2010) The change of prefrontal QEEG theta cordance as a predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressant treatments. Eur Neuropsychopharmacol 20(7):459–466PubMedGoogle Scholar
  19. Barry RJ, Clarke AR, McCarthy R, Selikowitz M, Brown CR (2009) Event-related potentials in children with attention-deficit/hyperactivity disorder and excess beta activity in the EEG. Acta Neuropsychologica 7(4):249Google Scholar
  20. Beebe DW, Rose D, Amin R (2010) Attention, learning, and arousal of experimentally sleep-restricted adolescents in a simulated classroom. J Adolesc Health 47(5):523–525PubMedCentralPubMedGoogle Scholar
  21. Belenky G, Wesensten NJ, Thorne DR, Thomas ML, Sing HC, Redmond DP, Russo MB, Balkin TJ (2003) Patterns of performance degradation and restoration during sleep restriction and subsequent recovery: a sleep dose-response study. J Sleep Res 12(1):1–12PubMedGoogle Scholar
  22. Bente D (1964) Die Insuffizienz des Vigilitätstonus eine klinische und elektroencephalographische Studie zum Aufbau narkoleptischer und neurasthenischer Syndrome, HabilitationsschriftGoogle Scholar
  23. Bierut LJ, Saccone NL, Rice JP, Goate A, Foroud T, Edenberg H, Almasy L, Conneally PM, Crowe R, Hesselbrock V, Li TK, Nurnberger J, Porjesz B, Schuckit MA, Tischfield J, Begleiter H, Reich T (2002) Defining alcohol-related phenotypes in humans, the collaborative study on the genetics of alcohol. Alcohol Res Health 26(3):208–213PubMedGoogle Scholar
  24. Blume WT (2006) Drug effects on EEG. J Clin Neurophysiol 23(4):306PubMedGoogle Scholar
  25. Bodenmann S, Rusterholz T, Dürr R, Stoll C, Bachmann V, Geissler E, Jaggi-Schwarz K, Landolt HP (2009) The functional Val158Met polymorphism of COMT predicts interindividual differences in brain alpha oscillations in young men. J Neurosci 29(35):10855–10862PubMedGoogle Scholar
  26. Boutros N, Fraenkel L, Feingold A (2005) A four-step approach for developing diagnostic tests in psychiatry: EEG in ADHD as a test case. J Neuropsychiatry Clin Neurosci 17(4):455–464PubMedGoogle Scholar
  27. Bruder GE, Stewart JW, Tenke CE, McGrath PJ, Leite P, Bhattacharya N, Quitkin FM (2001) Electroencephalographic and perceptual asymmetry differences between responders and nonresponders to an SSRI antidepressant. Biol Psychiatry 49(5):416–425PubMedGoogle Scholar
  28. Bruder GE, Tenke CE, Stewart JW, McGrath PJ, Quitkin FM (1999) Predictors of therapeutic response to treatments for depression: a review of electrophysiologic and dichotic listening studies. CNS Spectr 4(8):30–36PubMedGoogle Scholar
  29. Bschor T, Müller-Oerlinghausen B, Ulrich G (2001) Decreased level of EEG-vigilance in acute mania as a possible predictor for a rapid effect of methylphenidate: a case study. Clinical EEG (Electroencephalography) 32(1):36–39Google Scholar
  30. Candy M, Jones L, Williams R, Tookman A, King M (2008) Psychostimulants for depression. Cochrane Database Syst Rev (Online) 16(2): p. CD006722Google Scholar
  31. Capute AJ, Niedermeyer EFL, Richardson F (1968) The electroencephalogram in children with minimal cerebral dysfunction. Pediatrics 41(6):1104PubMedGoogle Scholar
  32. Chabot RJ, Serfontein G (1996) Quantitative electroencephalographic profiles of children with attention deficit disorder. Biol Psychiatry 40(10):951–963PubMedGoogle Scholar
  33. Chabot RJ, Orgill AA, Crawford G, Harris MJ, Serfontein G (1999) Behavioral and electrophysiologic predictors of treatment response to stimulants in children with attention disorders. J Child Neurol 14(6):343–351PubMedGoogle Scholar
  34. Clarke AR, Barry RJ, Dupuy FE, Heckel LD, McCarthy R, Selikowitz M, Johnstone SJ (2011) Behavioural differences between EEG-defined subgroups of children with attention-deficit/hyperactivity disorder. Clin Neurophysiol 122(7):1333–1341PubMedGoogle Scholar
  35. Clarke AR, Barry RJ, McCarthy R, Selikowitz M (1998) EEG analysis in attention-deficit/hyperactivity disorder: a comparative study of two subtypes. Psychiatry Res 81(1):19–29PubMedGoogle Scholar
  36. Clarke AR, Barry RJ, McCarthy R, Selikowitz M (2001a) EEG-defined subtypes of children with attention-deficit/hyperactivity disorder. Clin Neurophysiol 112(11):2098–2105PubMedGoogle Scholar
  37. Clarke AR, Barry RJ, McCarthy R, Selikowitz M (2001b) Excess beta activity in children with attention-deficit/hyperactivity disorder: an atypical electrophysiological group. Psychiatry Res 103(2–3):205–218PubMedGoogle Scholar
  38. Clarke AR, Barry RJ, McCarthy R, Selikowitz M, Croft RJ (2002) EEG differences between good and poor responders to methylphenidate in boys with the inattentive type of attention-deficit/hyperactivity disorder. Clin Neurophysiol 113(8):1191–1198PubMedGoogle Scholar
  39. Clarke AR, Barry RJ, McCarthy R, Selikowitz M, Clarke DC, Croft RJ (2003) Effects of stimulant medications on children with attention-deficit/hyperactivity disorder and excessive beta activity in their EEG. Clin Neurophysiol 114(9):1729–1737PubMedGoogle Scholar
  40. Cook IA, Hunter AM, Abrams M, Siegman B, Leuchter AF (2009) Midline and right frontal brain function as a physiologic biomarker of remission in major depression. Psychiatry Res: Neuroimaging 174:152–157PubMedCentralPubMedGoogle Scholar
  41. Cook IA, Leuchter AF, Morgan M, Witte E, Stubbeman WF, Abrams M, Rosenberg S, Uijtdehaage SH (2002) Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology 27(1):120–131PubMedGoogle Scholar
  42. Cook IA, Leuchter AF, Morgan ML, Stubbeman W, Siegman B, Abrams M (2005) Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study. J Psychiatr Res 39(5):461–466PubMedGoogle Scholar
  43. Cook IA, Leuchter AF, Witte E, Abrams M, Uijtdehaage SH, Stubbeman W, Rosenberg-Thompson S, Anderson-Hanley C, Dunkin JJ (1999) Neurophysiologic predictors of treatment response to fluoxetine in major depression. Psychiatry Res 85(3):263–273PubMedGoogle Scholar
  44. Cuijpers P, Reynolds CF, Donker T, Li J Andersson G, Beekman A (2012) Personalized treatment of adult depression: medication, psychotherapy or both? a systematic review. Depression and anxiety 29(10):855–864Google Scholar
  45. Cuijpers P, Smit F, Bohlmeijer E, Hollon SD, Andersson G (2010) Efficacy of cognitive-behavioural therapy and other psychological treatments for adult depression: meta-analytic study of publication bias. Br J Psychiatry 196:173–178PubMedGoogle Scholar
  46. Davids E, Kis B, Specka M, Gastpar M (2006) A pilot clinical trial of oxcarbazepine in adults with attention-deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry 30(6):1033–1038PubMedGoogle Scholar
  47. Debattista C, Kinrys G, Hoffman D, Goldstein C, Zajecka J, Kocsis J, Teicher M, Potkin S, Preda A, Multani G, Brandt L, Schiller M, Iosifescu D, Fava M (2010) The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression. J Psychiatr Res 45(1):64–75PubMedGoogle Scholar
  48. Dollman J, Ridley K, Olds T, Lowe E (2007) Trends in the duration of school-day sleep among 10–15 year-old South Australians between 1985 and 2004. Acta Paediatr 96(7):1011–1014PubMedGoogle Scholar
  49. Ducci F, Enoch MA, Yuan Q, Shen PH, White KV, Hodgkinson C, Albaugh B, Virkkunen M, Goldman D (2009) HTR3B is associated with alcoholism with antisocial behavior and alpha EEG power–an intermediate phenotype for alcoholism and co-morbid behaviors. Alcohol 43(1):73–84PubMedCentralPubMedGoogle Scholar
  50. Ebert D, Feistel H, Barocka A, Kaschka W (1994) Increased limbic blood flow and total sleep deprivation in major depression with melancholia. Psychiatry Res 55(2):101–109PubMedGoogle Scholar
  51. Ehlers CL, Garcia-Andrade C, Wall TL, Cloutier D, Phillips E (1999) Electroencephalographic responses to alcohol challenge in native American mission Indians. Biol Psychiatry 45(6):776–787PubMedGoogle Scholar
  52. Enoch MA, Schuckit MA, Johnson BA, Goldman D (2003) Genetics of alcoholism using intermediate phenotypes. Alcohol Clin Exp Res 27(2):169–176PubMedGoogle Scholar
  53. Enoch MA, Shen PH, Ducci F, Yuan Q, Liu J, White KV, Albaugh B, Hodgkinson CA, Goldman D (2008) Common genetic origins for EEG, alcoholism and anxiety: the role of CRH-BP. PLoS ONE 3(10):e3620PubMedCentralPubMedGoogle Scholar
  54. Fallone G, Acebo C, Arnedt JT, Seifer R, Carskadon MA (2001) Effects of acute sleep restriction on behavior, sustained attention, and response inhibition in children. Percept Mot Skills 93(1):213–229PubMedGoogle Scholar
  55. Fink M (2010) Remembering the lost neuroscience of pharmaco-EEG. Acta Psychiatr Scand 121(3):161–173PubMedGoogle Scholar
  56. Fink M, Kahn RL (1957) Relation of electroencephalographic delta activity to behavioral response in electroshock; quantitative serial studies. AMA Arch Neurol Psychiatry 78(5):516–525PubMedGoogle Scholar
  57. Frieling H, Tadić A, (2013) Value of genetic and epigenetic testing as biomarkers of response to antidepressant treatment. Int Rev Psychiatry (Abingdon, England) 25(5):572–578Google Scholar
  58. Gatt JM, Kuan SA, Dobson-Stone C, Paul RH, Joffe RT, Kemp AH, Gordon E, Schofield PR, Williams LM (2008) Association between BDNF Val66Met polymorphism and trait depression is mediated via resting EEG alpha band activity. Biol Psychol 79(2):275–284PubMedGoogle Scholar
  59. Golan N, Shahar E, Ravid S, Pillar G (2004) Sleep disorders and daytime sleepiness in children with attention-deficit/hyperactive disorder. Sleep 27(2):261–266PubMedGoogle Scholar
  60. Goodwin JE (1947) The significance of alpha variants in the EEG, and their relationship to an epileptiform syndrome. Am J Psychiatry 104(6):369–379PubMedGoogle Scholar
  61. Gottesman II, Gould TD (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160(4):636–645PubMedGoogle Scholar
  62. De Gruttola VG, Clax P, DeMets DL, Downing GJ, Ellenberg SS, Friedman L, Gail MH, Prentice R, Wittes J, Zeger SL (2001) Considerations in the evaluation of surrogate endpoints in clinical trials, summary of a national institutes of health workshop. Control Clin Trials 22(5):485–502PubMedGoogle Scholar
  63. Halasz P, Janszky J, Barcs G, Szcs A (2004) Generalised paroxysmal fast activity (GPFA) is not always a sign of malignant epileptic encephalopathy. Seizure 13(4):270–276PubMedGoogle Scholar
  64. Hamani C, Mayberg H, Stone S, Laxton A, Haber S, Lozano AM (2011) The subcallosal cingulate gyrus in the context of major depression. Biol Psychiatry 69(4):301–308PubMedGoogle Scholar
  65. Hefner G, Laib AK, Sigurdsson H, Hohner M, Hiemke C (2013) The value of drug and metabolite concentration in blood as a biomarker of psychopharmacological therapy. Int Rev Psychiatry 25(5):494–508PubMedGoogle Scholar
  66. Hegerl U, Hensch T (2012) The vigilance regulation model of affective disorders and ADHD. Neurosci Biobehav Rev. doi: 10.1016/j.neubiorev.2012.10.008
  67. Hegerl U, Himmerich H, Engmann B, Hensch T (2010) Mania and attention-deficit/hyperactivity disorder: common symptomatology, common pathophysiology and common treatment? Curr Opin Psychiatry 23(1):1–7PubMedGoogle Scholar
  68. Hegerl U, Wilk K, Olbrich S, Schoenknecht P, Sander C (2012) Hyperstable regulation of vigilance in patients with major depressive disorder. World J Biol Psychiatry 13(6):436–446PubMedGoogle Scholar
  69. Hemmer SA, Pasternak JF, Zecker SG, Trommer BL (2001) Stimulant therapy and seizure risk in children with ADHD. Pediatr Neurol 24(2):99–102PubMedGoogle Scholar
  70. Hermens DF, Cooper NJ, Kohn M, Clarke S, Gordon E (2005) Predicting stimulant medication response in ADHD: evidence from an integrated profile of neuropsychological, psychophysiological and clinical factors. J Integr Neurosci 4(1):107–121PubMedGoogle Scholar
  71. Hoebert M, van der Heijden KB, van Geijlswijk IM, Smits MG (2009) Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia. J Pineal Res 47(1):1–7PubMedGoogle Scholar
  72. Hughes JR, DeLeo AJ, Melyn MA (2000) The electroencephalogram in attention deficit-hyperactivity disorder: emphasis on epileptiform discharges. Epilepsy Behav: E&B 1(4):271–277Google Scholar
  73. Iglowstein I, Jenni G, Molinari L, Largo H (2003) Sleep duration from infancy to adolescence: reference values and generational trends. Pediatrics 111(2):302–307PubMedGoogle Scholar
  74. Iosifescu DV, Greenwald S, Devlin P, Mischoulon D, Denninger JW, Alpert JE, Fava M (2009) Frontal EEG predictors of treatment outcome in major depressive disorder. Eur Neuropsychopharmacol 19(11):772–777PubMedGoogle Scholar
  75. Ishii R, Shinosaki K, Ukai S, Inouye T, Ishihara T, Yoshimine T, Hirabuki N, Asada H, Kihara T, Robinson SE, Takeda M (1999) Medial prefrontal cortex generates frontal midline theta rhythm. NeuroReport 10(4):675–679PubMedGoogle Scholar
  76. Itil TM (1983) The discovery of antidepressant drugs by computer-analyzed human cerebral bio-electrical potentials (CEEG). Prog Neurobiol 20(3–4):185–249Google Scholar
  77. Itil TM, Rizzo AE (1967) Behavior and quantitative EEG correlations during treatment of behavior-disturbed adolescents. Electroencephalogr Clin Neurophysiol 23(1):81PubMedGoogle Scholar
  78. Itil TM, Marasa J, Saletu B, Davis S, Mucciardi AN (1975) Computerized EEG: predictor of outcome in schizophrenia. J Nerv Ment Dis 160(3):118–203PubMedGoogle Scholar
  79. Jasper HH, Solomon P, Bradley C (1938) Electroencephalographic analyses of behavior problem children. Am J Psychiatry 95(3):641Google Scholar
  80. Ji Y, Hebbring S, Zhu H, Jenkins GD, Biernacka J, Snyder K, Drews M, Fiehn O, Zeng Z, Schaid D, Mrazek DA, Kaddurah-Daouk R, Weinshilboum RM (2011) Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics. Clin Pharmacol Ther 89(1):97–104PubMedCentralPubMedGoogle Scholar
  81. Johnson CH, Gonzalez FJ (2012) Challenges and opportunities of metabolomics. J Cell Physiol 227(8):2975–2981PubMedGoogle Scholar
  82. Joyce PR, Paykel ES (1989) Predictors of drug response in depression. Arch Gen Psychiatry 46(1):89–99PubMedGoogle Scholar
  83. Knott V, Mahoney C, Kennedy S, Evans K (2000) Pre-treatment EEG and it’s relationship to depression severity and paroxetine treatment outcome. Pharmacopsychiatry 33(6):201–205PubMedGoogle Scholar
  84. Kuo CC, Tsai JF (2010) Cordance or antidepressant treatment response (ATR) index?. Psychiatry Res 180(1):60 (author reply 61–2)Google Scholar
  85. Lander ES (2011) Initial impact of the sequencing of the human genome. Nature 470(7333):187–197PubMedGoogle Scholar
  86. Lansbergen M, Arns M, van Dongen-Boomsma M, Spronk D, Buitelaar JK (2011) The increase in theta/beta ratio on resting state EEG in boys with attention-deficit/hyperactivity disorder is mediated by slow alpha peak frequency. Prog Neuropsychopharmacol Biol Psychiatry 35:47–52PubMedGoogle Scholar
  87. Lemere F (1936) The significance of individual differences in the Berger rhythm. Brain: J Neurol 59:366–75Google Scholar
  88. Lennox-Buchtal M, Buchtal F, Rosenfalck P (1960) Correlation of electroencephalographic findings with crash rate of military jet pilots. Epilepsia 1:366–372Google Scholar
  89. Leuchter AF, Cook IA, Gilmer WS, Marangell LB, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, Fava M, Iosifescu D, Greenwald S (2009a) Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Res 169(2):132–138PubMedGoogle Scholar
  90. Leuchter AF, Cook IA, Lufkin RB, Dunkin J, Newton TF, Cummings JL, Mackey JK, Walter DO (1994a) Cordance: a new method for assessment of cerebral perfusion and metabolism using quantitative electroencephalography. NeuroImage 1(3):208–219PubMedGoogle Scholar
  91. Leuchter AF, Cook IA, Marangell LB, Gilmer WS, Burgoyne KS, Howland RH, Trivedi MH, Zisook S, Jain R, McCracken JT, Fava M, Iosifescu D, Greenwald S (2009b) Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in major depressive disorder: results of the BRITE-MD study. Psychiatry Res 169(2):124–131PubMedGoogle Scholar
  92. Leuchter AF, Cook IA, Mena I, Dunkin JJ, Cummings JL, Newton TF, Migneco O, Lufkin RB, Walter DO, Lachenbruch PA (1994b) Assessment of cerebral perfusion using quantitative EEG cordance. Psychiatry Res 55(3):141–152PubMedGoogle Scholar
  93. Leuchter AF, Cook IA, Witte EA, Morgan M, Abrams M (2002) Changes in brain function of depressed subjects during treatment with placebo. Am J Psychiatry 159(1):122–129PubMedGoogle Scholar
  94. Leuchter AF, Uijtdehaage SH, Cook IA, O’Hara R, Mandelkern M (1999) Relationship between brain electrical activity and cortical perfusion in normal subjects. Psychiatry Res 90(2):125–140PubMedGoogle Scholar
  95. Matricciani L, Olds T, Williams M (2011) A review of evidence for the claim that children are sleeping less than in the past. Sleep 34(5):651–659PubMedCentralPubMedGoogle Scholar
  96. Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL, Silva JA, McGinnis S, Glass TG, Martin CC, Fox PT (1997) Cingulate function in depression: a potential predictor of treatment response. NeuroReport 8(4):1057–1061PubMedGoogle Scholar
  97. Menke A (2013) Gene expression: biomarker of antidepressant therapy? Int Rev Psychiatry 25(5):579–591PubMedGoogle Scholar
  98. Miano S, Parisi P, Villa MP (2012) The sleep phenotypes of attention deficit hyperactivity disorder: the role of arousal during sleep and implications for treatment. Med Hypotheses 79(2):147–53Google Scholar
  99. Miller G (2010) Is pharma running out of brainy ideas? Science 329(5991):502PubMedGoogle Scholar
  100. Mintz M, Legoff D, Scornaienchi J, Brown M, Levin-Allen S, Mintz P, Smith C (2009) The underrecognized epilepsy spectrum: the effects of levetiracetam on neuropsychological functioning in relation to subclinical spike production. J Child Neurol 24(7):807–815PubMedGoogle Scholar
  101. Molina BS, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B, Jensen PS, Epstein JN, Hoza B, Hechtman L, Abikoff HB, Elliott GR, Greenhill LL, Newcorn JH, Wells KC, Wigal T, Gibbons RD, Hur K, Houck PR, MTA Cooperative Group (2009) The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry 48(5):484–500Google Scholar
  102. Monastra VJ, Lubar JF, Linden M, VanDeusen P, Green G, Wing W, Phillips A, Fenger TN (1999) Assessing attention deficit hyperactivity disorder via quantitative electroencephalography: an initial validation study. Neuropsychology 13(3):424–433PubMedGoogle Scholar
  103. Monastra VJ, Monastra DM, George S (2002) The effects of stimulant therapy, EEG biofeedback, and parenting style on the primary symptoms of attention-deficit/hyperactivity disorder. Appl Psychophysiology Biofeedback 27(4):231–249Google Scholar
  104. Mulert C, Juckel G, Brunnmeier M, Karch S, Leicht G, Mergl R, Möller HJ, Hegerl U, Pogarell O (2007) Prediction of treatment response in major depression: integration of concepts. J Affect Disord 98(3):215–225PubMedGoogle Scholar
  105. Niedermeyer E, Lopes da Silva FH (1993) Electroencephalography : basic principles, clinical applications, and related fields. Williams & Williams, BaltimoreGoogle Scholar
  106. Nobler MS, Luber B, Moeller JR, Katzman GP, Prudic J, Devanand DP, Dichter GS, Sackeim HA (2000) Quantitative EEG during seizures induced by electroconvulsive therapy: relations to treatment modality and clinical features. I. Global analyses. The journal of ECT 16(3):211PubMedGoogle Scholar
  107. Olbrich S, Arns SM (2013) EEG biomarkers in major depressive disorder: discriminative power and prediction of treatment response. Int Rev Psychiatry 25(5):604–618PubMedGoogle Scholar
  108. Olbrich S, Sander C, Minkwitz J, Chittka T, Mergl R, Hegerl U, Himmerich H (2012) EEG vigilance regulation patterns and their discriminative power to separate patients with major depression from healthy controls. Neuropsychobiology 65(4):188–194PubMedGoogle Scholar
  109. Parmeggiani A, Barcia G, Posar A, Raimondi E, Santucci M, Scaduto MC (2010) Epilepsy and EEG paroxysmal abnormalities in autism spectrum disorders. Brain Dev 32(9):783–789PubMedGoogle Scholar
  110. Pascual-Marqui RD, Michel CM, Lehmann D (1994) Low resolution electromagnetic tomography: a new method for localizing electrical activity in the brain. Int J Psychophysiol: Official J Int Organ Psychophysiol 18(1):49–65Google Scholar
  111. Pizzagalli DA (2011) Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology 36:183–206PubMedCentralPubMedGoogle Scholar
  112. Pizzagalli DA, Oakes TR, Davidson RJ (2003) Coupling of theta activity and glucose metabolism in the human rostral anterior cingulate cortex: an EEG/PET study of normal and depressed subjects. Psychophysiology 40(6):939–949PubMedGoogle Scholar
  113. Pollock VE, Schneider LS (1990) Quantitative, waking EEG research on depression. Biol Psychiatry 27(7):757–780PubMedGoogle Scholar
  114. Posthuma D, Neale MC, Boomsma DI, de Geus EJ (2001) Are smarter brains running faster? Heritability of alpha peak frequency, IQ, and their interrelation, Behavior genetics 31(6):567–579Google Scholar
  115. Quinones MP, Kaddurah-Daouk R (2009) Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. Neurobiol Dis 35(2):165–176PubMedGoogle Scholar
  116. Richter PL, Zimmerman EA, Raichle ME, Liske E (1971) Electroencephalograms of 2,947 United States air force academy cadets (1965–1969). Aerosp Med 42(9):1011–1014PubMedGoogle Scholar
  117. Roth M, Kay DW, Shaw J, Green J (1957) Prognosis and pentothal induced electroencephalographic changes in electro-convulsive treatment; an approach to the problem of regulation of convulsive therapy. Electroencephalogr Clin Neurophysiol 9(2):225–237PubMedGoogle Scholar
  118. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 163(11):1905–1917PubMedGoogle Scholar
  119. Rybak YE, McNeely HE, Mackenzie BE, Jain UR, Levitan RD (2006) An open trial of light therapy in adult attention-deficit/hyperactivity disorder. J Clin Psychiatry 67(10):1527–1535PubMedGoogle Scholar
  120. Sander C, Arns M, Olbrich S, Hegerl U (2010) EEG-vigilance and response to stimulants in paediatric patients with attention deficit/hyperactivity disorder. Clin Neurophysiol 121:1511–1518PubMedGoogle Scholar
  121. Satterfield JH, Cantwell DP, Saul RE, Lesser LI, Podosin RL (1973) Response to stimulant drug treatment in hyperactive children: prediction from EEG and neurological findings. J Autism Child Schizophr 3(1):36–48PubMedGoogle Scholar
  122. Satterfield JH, Lesser LI, Podosin RL (1971) Evoked cortical potentials in hyperkinetic children. Calif Med 115(3):48PubMedCentralPubMedGoogle Scholar
  123. Savitz JB, Rauch SL, Drevets WC (2013) Clinical application of brain imaging for the diagnosis of mood disorders: the current state of play. Mol Psychiatry 18(5):528–539PubMedCentralPubMedGoogle Scholar
  124. Schoenknecht P, Olbrich S, Sander C, Spindler P, Hegerl U (2010) Treatment of acute mania with modafinil monotherapy. Bio Psychiatry 67:e55–e57Google Scholar
  125. Schwartz J, Feldstein S, Fink M, Shapiro DM, Itil TM (1971) Evidence for a characteristic EEG frequency response to thiopental. Electroencephalogr Clin Neurophysiol 31(2):149–153PubMedGoogle Scholar
  126. Silva RR, Munoz DM, Alpert M (1996) Carbamazepine use in children and adolescents with features of attention-deficit hyperactivity disorder: a meta-analysis. J Am Acad Child Adolesc Psychiatry 35(3):352–358PubMedGoogle Scholar
  127. Simon GE, Perlis RH (2010) Personalized medicine for depression: can we match patients with treatments? Am J Psychiatry 167(12):1445–1455PubMedCentralPubMedGoogle Scholar
  128. Small JG, Milstein V, Medlock CE (1997) Clinical EEG findings in mania. Clinical EEG (Electroencephalography) 28(4):229–235Google Scholar
  129. Smit DJ, Boersma M, van Beijsterveldt CE, Posthuma D, Boomsma DI, Stam CJ, de Geus EJ (2010) Endophenotypes in a dynamically connected brain. Behav Genet 40(2):167–177PubMedCentralPubMedGoogle Scholar
  130. Smit DJ, Posthuma D, Boomsma DI, Geus EJ (2005) Heritability of background EEG across the power spectrum. Psychophysiology 42(6):691–697PubMedGoogle Scholar
  131. Smith GS, Reynolds CF, Pollock B, Derbyshire S, Nofzinger E, Dew MA, Houck PR, Milko D, Meltzer CC, Kupfer DJ (1999) Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression. Am J Psychiatry 156(5):683–689PubMedGoogle Scholar
  132. Snyder SM, Hall JR (2006) A meta-analysis of quantitative EEG power associated with attention-deficit hyperactivity disorder. J Clin Neurophysiol 23(5):440–455PubMedGoogle Scholar
  133. Spronk D, Arns M, Barnett KJ, Cooper NJ, Gordon E (2011) An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: a pilot study. J Affect Disord 128:41–48PubMedGoogle Scholar
  134. Stern JM, Engel J (2004) Atlas of EEG patterns. Lippincott Williams & Wilkins, BaltimoreGoogle Scholar
  135. Stubbeman WF, Leuchter AF, Cook IA, Shurman BD, Morgan M, Gunay I, Gonzalez S (2004) Pretreatment neurophysiologic function and ECT response in depression. J ECT 20(3):142–144PubMedGoogle Scholar
  136. Suffin SC, Emory WH (1995) Neurometric subgroups in attentional and affective disorders and their association with pharmacotherapeutic outcome. Clinical EEG (Electroencephalography) 26(2):76–83Google Scholar
  137. Swanson JM, Hinshaw SP, Arnold LE, Gibbons RD, Marcus S, Hur K, Jensen PS, Vitiello B, Abikoff HB, Greenhill LL, Hechtman L, Pelham WE, Wells KC, Conners CK, March JS, Elliott GR, Epstein JN, Hoagwood K, Hoza B, Molina BS, Newcorn JH, Severe JB, Wigal T (2007) Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. J Am Acad Child Adolesc Psychiatry 46(8):1003–1014PubMedGoogle Scholar
  138. Tenke CE, Kayser J, Manna CG, Fekri S, Kroppmann CJ, Schaller JD, Alschuler DM, Stewart JW, McGrath PJ, Bruder GE (2011) Current source density measures of electroencephalographic alpha predict antidepressant treatment response. Biol Psychiatry 70(4):388–394PubMedCentralPubMedGoogle Scholar
  139. Ulrich G, Fürstenberg U (1999) Quantitative assessment of dynamic electroencephalogram (EEG) organization as a tool for subtyping depressive syndromes. Eur Psychiatry 14(4):217–229PubMedGoogle Scholar
  140. Ulrich G, Herrmann WM, Hegerl U, Müller-Oerlinghausen B (1990) Effect of lithium on the dynamics of electroencephalographic vigilance in healthy subjects. J Affect Disord 20(1):19–25PubMedGoogle Scholar
  141. Ulrich G, Renfordt E, Zeller G, Frick K (1984) Interrelation between changes in the EEG and psychopathology under pharmacotherapy for endogenous depression. Contrib Predictor Question, Pharmacopsychiatry 17(6):178–183Google Scholar
  142. van Beijsterveldt CE, van Baal GC (2002) Twin and family studies of the human electroencephalogram: a review and a meta-analysis. Biol Psychol 61(1–2):111–138PubMedGoogle Scholar
  143. van der Heijden KB, Blok MJ, Spee K, Archer SN, Smits MG, Curfs LM, Gunning WB (2005) No evidence to support an association of PER3 clock gene polymorphism with ADHD-related idiopathic chronic sleep onset insomnia. Biol Rhythm Res 36(5):381–388Google Scholar
  144. Van Dongen HP, Maislin G, Mullington JM, Dinges DF (2003) The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 26(2):117–126PubMedGoogle Scholar
  145. Van Veen MM, Kooij JJ, Boonstra AM, Gordijn MC, Van Someren EJ (2010) Delayed circadian rhythm in adults with attention-deficit/hyperactivity disorder and chronic sleep-onset insomnia. Biol Psychiatry 67(11):1091–1096PubMedGoogle Scholar
  146. Vogel F (1970) The genetic basis of the normal human electroencephalogram (EEG). Hum Genet 10(2):91–114Google Scholar
  147. Volavka J, Feldstein S, Abrams R, Dornbush R, Fink M (1972) EEG and clinical change after bilateral and unilateral electroconvulsive therapy. Electroencephalogr Clin Neurophysiol 32(6):631–639PubMedGoogle Scholar
  148. Walter W, Dovey VJ (1944) Electro-encephalography in cases of sub-cortical tumour. J Neurol Neurosurg Psychiatry 7(3–4):57PubMedCentralPubMedGoogle Scholar
  149. Winterer G, Mahlberg R, Smolka MN, Samochowiec J, Ziller M, Rommelspacher HP, Herrmann WM, Schmidt LG, Sander T (2003) Association analysis of exonic variants of the GABA B-receptor gene and alpha electroencephalogram voltage in normal subjects and alcohol-dependent patients. Behav Genet 33(1):7–15PubMedGoogle Scholar
  150. Wood JG, Crager JL, Delap CM, Heiskell KD (2007) Beyond methylphenidate: nonstimulant medications for youth with ADHD. J Attention Dis, 11(3):341–350Google Scholar
  151. Wu J, Buchsbaum MS, Gillin JC, Tang C, Cadwell S, Wiegand M, Najafi A, Klein E, Hazen K, Bunney WE, Fallon JH, Keator D (1999) Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry 156(8):1149–1158PubMedGoogle Scholar
  152. Wu JC, Gillin JC, Buchsbaum MS, Hershey T, Johnson JC, Bunney WE (1992) Effect of sleep deprivation on brain metabolism of depressed patients. Am J Psychiatry 149(4):538–543PubMedGoogle Scholar
  153. Yasuhara A (2010) Correlation between EEG abnormalities and symptoms of autism spectrum disorder (ASD). Brain Dev 32(10):791–798PubMedGoogle Scholar
  154. Zoon HF, Veth CP, Arns M, Drinkenburg WH, Talloen W, Peeters PJ, Kenemans JL (2013) EEG alpha power as an intermediate measure between brain-derived neurotrophic factor Val66Met and depression severity in patients with major depressive disorder. J Clin Neurophysiol 30(3):261–267 PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Department of Experimental PsychologyUtrecht UniversityUtrechtThe Netherlands
  2. 2.Research Institute BrainclinicsNijmegenThe Netherlands
  3. 3.Department for Psychiatry and PsychotherapyUniverstiy LeipzigLeipzigGermany

Personalised recommendations